ZYUS LIFE SCIENCES CORPORATION

Communiqués ZYUS Life Sciences Corporation

Actions

ZYUS

CA9899601095

Temps Différé Toronto S.E. Autres places de cotation 18:06:05 12/07/2024			Varia. 5j.	Varia. 1 janv.
1,04 ^CAD	+2,97 %		+0,97 %	+15,56 %

29/05	ZYUS Life Sciences Corporation annonce ses resultats pour le premier trimestre clos le 31 mars 2024	CI
07/05	ZYUS Life Sciences Corporation publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ZYUS Announces Completion of Its Annual Filings	08/05	AQ
INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9	08/05	BU
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management	23/04	BU
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke	02/02	AQ
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research	10/01	AQ
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin Softgel Capsules for Advanced Cancer Pain Management	06/12	AQ
ZYUS Life Sciences Corporation Reports Q3 2023 Results	30/11	AQ
ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin Softgels	22/11	AQ
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets	25/10/23	AQ
ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee	01/09/23	AQ
ZYUS Life Sciences Corp. Closes the Market	19/07/23	AQ
ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee	30/06/23	AQ
Phoenix Canada Oil Company Limited Announces Successful Close of Subscription Receipt Financing Required for Reverse Takeover Transaction with ZYUS Life Sciences Inc. and Record Date for Warrant Distribution	07/06/23	AQ
ZYUS Announces Concurrent Private Placement of Subscription Receipts in Connection With Previously Announced RTO	29/03/23	AQ
Phoenix Canada Oil Company Limited Receives Conditional Approval for Reverse Takeover Transaction with ZYUS Life Sciences Inc.	13/03/23	GL
Phoenix Canada Oil Company Limited Signs Definitive Agreement for Reverse Takeover Transaction with ZYUS Life Sciences Inc	17/11/22	AQ
Phoenix Canada Oil Company Limited Signs Letter of Intent for Reverse Takeover Transaction with ZYUS Life Sciences Inc	31/05/22	AQ
IIROC Trading Halt - PCO	30/05/22	AQ
Aurora Cannabis Announces Appointment of Two New Independent Directors Friedmann and Detlefsen Bring Significant Experience in Consumer Products and Marketing	07/02/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action ZYUS
Actualités ZYUS Life Sciences Corporation
Communiqués

Nos Contenus Gratuits vous Aident à Sécuriser et Augmenter la Performance de vos Investissements

Sécuriser mes Investissements

fermer